Neurological And Biochemical Aspects Of Eating Disorders: Review Article

Tania Leme da Rocha Martinez

doi:10.58372/2835-6276.1196

Authors

Tania Leme da Rocha Martinez

DOI:

https://doi.org/10.58372/2835-6276.1196

Keywords:

Anorexia, Behavioral, Biochemical, Bulimia, Neurological

Abstract

Current studies on the epithalamic nuclei, referring to appetite, have further enriched the doubts about the pathogenesis of anorexia, bulimia and obesity, with the influence on the nuclei of the lateral hypothalamus, which produces lack of appetite thanks to the release of leptin, but which can also be produced by orexin, galanin, or hypocreatine. After food intake and consequent increase in fat levels, leptin - composed of alpha-MSH (an anorectic peptide, melanocyte-stimulating hormone) and CART (peptide regulated by cocaine and amphetamine) - is high in the blood, activating the arcuate nucleus and increasing adrenocorticotropic hormone (ACTH) and thyroid-stimulating hormone (TSH). The metabolic rate is high in obese people, because it is proportional to being overweight: they are less effective in counterbalancing or adjusting their metabolic needs. Modernly, the metabolic phase is valued, in which adenosinotriphosphatase exerts a special power. The mobilization of fat, containing more triglycerides, occurs by the degradation of these into glycerol and free fatty acids, which are transported together with albumin. This transformation is possible because an enzyme, lipase, is activated by epinephrine, glucagon, ACTH, TSH and somatotropin. Mobilization depends on the activation of intracellular lipase. These stimuli are studied, but the influence of glycemic levels - hypo and hyperglycemic - on the action of insulin, or not, and the amount of corticosteroid, lysine, carnitine and the cupric cofactor dopamine-beta-hydrolaxilase, which converts dopamine into norepinephrine, and its low can produce anorexia nervosa, is recognized.

References

Alóe F, Azevedo AP, Hasan R. Sleep-wake cycle mechanisms. Rev Bras Psiquiatr. 2005; 27(Supl I):33-39. https://www.scielo.br/j/rbp/a/B7HS9XTyWBpjhWsfBL6JTqn/?format=pdf&lang=en

Gaudio S, Carducci F, Piervincenzi C, Olivo G, Schiöth HB. Altered thalamo-cortical and occipital-parietal-temporal-frontal white matter connections in patients with anorexia and bulimia nervosa: a systematic review of diffusion tensor imaging studies. J Psychiatry Neurosci. 2019; 44(5):324-339. doi: 10.1503/jpn.180121

Bear MF, Connors BW, Paradiso MA. Neurociências: Desvendando o Sistema Nervoso [Neurosciences: Unraveling the Nervous System]. Porto Alegre, Brasil: Artmed 2002. https://edisciplinas.usp.br/pluginfile.php/7626309/mod_resource/content/2/Mark%20F.%20Bear%20et%20al.%20-%20Neuroci%C3%AAncias%20Desvendando%20o%20Sistema%20Nervoso.pdf

Morgan CA 3rd, Wang S, Rasmusson A, Hazlett G, Anderson G, Charney DS. Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress. Psychosom Med. 2001; 63(3):412-422. doi: 10.1097/00006842-200105000-00010

Monteleone P, Martiadis V, Colurcio B, Maj M. Leptin secretion is related to chronicity and severity of the illness in bulimia nervosa. Psychosom Med. 2002; 64(6):874-879. doi: 10.1097/01.psy.0000024239.11538.a5

James WP, Davies HL, Bailes J, Dauncey MJ. Elevated metabolic rates in obesity. Lancet. 1978; 1(8074):1122-1125. doi: 10.1016/s0140-6736(78)90300-8

Krieger DT, Liotta AS, Brownstein MJ, Zimmerman EA. ACTH, beta-lipotropin, and related peptides in brain, pituitary, and blood. Recent Prog Horm Res. 1980; 36:277-344. doi: 10.1016/b978-0-12-571136-4.50015-2

Satyal MK, Basso JC, Tegge AN, Metpally AR, Bickel WK. A novel model of obesity prediction: Neurobehaviors as targets for treatment. Behav Neurosci. 2021; 135(3):426-442. doi: 10.1037/bne0000385

Flier J, Edwards MW, Daly JW, Myers CW. Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na+, K+-ATPase. Science. 1980; 208(4443):503-505. doi: 10.1126/science.6245447

Corcos M, Guilbaud O, Chaouat G, Cayol V, Speranza M, Chambry J, et al. Cytokines and anorexia nervosa. Psychosom Med. 2001; 63(3):502-504. doi: 10.1097/00006842-200105000-00021

Mayer J. Genetic, traumatic and environmental factors in the etiology of obesity. Physiol Rev. 1953; 33(4):472-508. doi: 10.1152/physrev.1953.33.4.472

Ralph AF, Brennan L, Byrne S, Caldwell B, Farmer J, Hart LM, et al. Management of eating disorders for people with higher weight: clinical practice guideline. J Eat Disord. 2022; 10(1):121. doi: 10.1186/s40337-022-00622-w

Zarafonetis CJ, Miller GM, Seifter J, Baeder D, Myerson RM, Steiger WA. Metabolic studies in patients receiving lipid mobilizer hormone. Am J Med Sci. 1957; 234(5):493-504 passim. doi: 10.1097/00000441-195711000-00001

Schaumberg K, Welch E, Breithaupt L, Hübel C, Baker JH, Munn-Chernoff MA, et al. The science behind the academy for eating disorders' nine truths about eating disorders. Eur Eat Disord Rev. 2017; 25(6):432-450. doi: 10.1002/erv.2553

Hyslop PA, York DA. Membrane fluidity and adenylate cyclase activity in genetically obese mice. Biochem Biophys Res Commun. 1980; 92(3):819-824. doi: 10.1016/0006-291x(80)90776-7

Horwitz DL. What causes obesity? Compr Ther. 1980; 6(4):3-4. PMID: 7389292.

Yamauchi Y, Suzuki J. A male patient exhibiting binge-eating following head contusion suffered in a traffic accident. Jpn J Psychosom Med. 1980; 20(2):141-150. doi: https://doi.org/10.15064/jjpm.20.2_141

O'Brien CP, Stunkard AJ, Ternes JW. Absence of naloxone sensitivity in obese humans. Psychosom Med. 1982; 44(2):215-223. doi: 10.1097/00006842-198205000-00007

McCloy J, McCloy RF. Enkephalins, hunger, and obesity. Lancet. 1979; 2(8134):156. doi: 10.1016/s0140-6736(79)90047-3

King BM, Castellanos FX, Kastin AJ, Berzas MC, Mauk MD, Olson GA, et al. Naloxone-induced suppression of food intake in normal and hypothalamic obese rats. Pharmacol Biochem Behav. 1979; 11(6):729-732. doi: 10.1016/0091-3057(79)90272-7

Chandra RK, Kutty KM. Immunocompetence in obesity. Acta Paediatr Scand. 1980; 69(1):25-30. doi: 10.1111/j.1651-2227.1980.tb07024.x

Durrant ML, Royston P. The long-term effect of energy intake on salivation, hunger, and appetite ratings, and estimates of energy intake in obese patients. Psychosom Med. 1980; 42(4):385-395. doi: 10.1097/00006842-198007000-00001

Godoy Moreira MSCL. Adolescente e bulimia: escravo bem temperado [Teenager and bulimia: well-seasoned slave]. In: Bruno CANB, org. Distúrbios alimentares - uma contribuição da psicanálise [Eating disorders - a contribution of psychoanalysis]. São Paulo: Imago 2010; 215-224.

Glucksman ML, Hirsch J. The response of obese patients to weight reduction. 3. The perception of body size. Psychosom Med. 1969; 31(1):1-7. doi: 10.1097/00006842-196901000-00001

Garner DM, Garfinkel PE, Stancer HC, Moldofsky H. Body image disturbances in anorexia nervosa and obesity. Psychosom Med. 1976; 38(5):327-336. doi: 10.1097/00006842-197609000-00005

Meyer JE, Pudel VE. Experimental feeding in man: a behavioral approach to obesity. Psychosom Med. 1977; 39(3):153-157. doi: 10.1097/00006842-197705000-00001

Stunkard A. Obesity and the denial of hunger. Psychosom Med. 1959; 21:281-290. doi: 10.1097/00006842-195907000-00004

Bruch H. Eating Disorders. Obesity, anorexia nervosa, and the person within. Reino Unido: Basic Books 1973.